Evidence map›Paper›PMID 34277955›Full record

ArticleHealth science reports2021

Feasibility of endoscopic evaluation of

Ryosuke Hirai, Mami Hirai, Yuichi Shimodate, Mariko Minami, Sho Ishikawa, Takafumi Kanadani, Rio Takezawa, Akira Doi, Naoyuki Nishimura, Hirokazu Mouri and 3 more

Open access · goldAbstract read
In one paragraph

Article in Health science reports, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
2.3field-weighted citation impact, top 12% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 12 citations in OpenAlex.

  1. Article
  2. Article
  3. Gut and liver · 2023
    Article
  4. Article
  5. Validation of a Novel Endoscopic Feature that PredictsThe Korean journal of helicobacter and upper gastrointestinal research · 2023
    Article
  6. Article
  7. Article
  8. Gastric Cancer Screening in Japan: A Narrative Review.Journal of clinical medicine · 2022
    Review
  9. Feasibility of endoscopic evaluation ofHealth science reports · 2021
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 2 institutions in 1 country.

Ryosuke HiraiDepartment of Gastroenterology and Hepatology Kurashiki Central Hospital Okayama Japan.ORCID https://orcid.org/0000-0002-3602-9695
Mami HiraiDepartment of Gastroenterology and Hepatology Okayama University Hospital Okayama Japan.ORCID https://orcid.org/0000-0002-9696-2858
Yuichi ShimodateDepartment of Gastroenterology and Hepatology Kurashiki Central Hospital Okayama Japan.ORCID https://orcid.org/0000-0001-9603-1896
Mariko MinamiDepartment of Gastroenterology and Hepatology Kurashiki Central Hospital Okayama Japan.
Sho IshikawaDepartment of Gastroenterology and Hepatology Kurashiki Central Hospital Okayama Japan.
Takafumi KanadaniDepartment of Gastroenterology and Hepatology Kurashiki Central Hospital Okayama Japan.
Rio TakezawaDepartment of Gastroenterology and Hepatology Kurashiki Central Hospital Okayama Japan.
Akira DoiDepartment of Gastroenterology and Hepatology Kurashiki Central Hospital Okayama Japan.
Naoyuki NishimuraDepartment of Gastroenterology and Hepatology Kurashiki Central Hospital Okayama Japan.
Hirokazu MouriDepartment of Gastroenterology and Hepatology Kurashiki Central Hospital Okayama Japan.
Kazuhiro MatsuedaDepartment of Gastroenterology and Hepatology Kurashiki Central Hospital Okayama Japan.
Hiroshi YamamotoDepartment of Gastroenterology and Hepatology Kurashiki Central Hospital Okayama Japan.
Motowo MizunoDepartment of Gastroenterology and Hepatology Kurashiki Central Hospital Okayama Japan.ORCID https://orcid.org/0000-0001-6974-4401
Kurashiki Central Hospital · JPOkayama University Hospital · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

BACKGROUND AND

aimsWe have started a new population-based endoscopic gastric cancer screening program in Kurashiki city with consideration of

methodsData were collected from 1784 subjects without past eradication of

resultsThe endoscopic diagnoses were nongastritis, 1215 (68.1%); active or inactive gastritis, 469 (26.3%); and undefined, 23 (1.3%). With the ABC method as a reference standard, the false-negative rate of the endoscopic judgment for

conclusionsEndoscopic diagnosis of

Indexed as

atrophic gastritiscancer screeninggastric cancergastrointestinal endoscopyHelicobacter pylori

Identifiers

PMID34277955
PMCPMC8279217
OpenAlexW3184346890

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.